|
|
| |
 |
Search Results  lupin ltd |
|
|
| |
| Lupin sales growth leaps over volume growth | 22-OCT-09 |
|
| Lupin— the largest manufacturer of anti-TB drugs in the world — has recorded one of the sharpest rise in sales in the domestic market over the last 12 months, according to the latest data available from research firm ORG-IMS. |
|
|
|
| Nestle, Takeda sue Lupin, Torrent over patents | 09-JUL-09 |
|
| Galderma Laboratories, a joint venture dermatology company between Nestle and L'Oreal, and the New York University have sued Lupin Ltd for infringing the patent rights of one of its main drugs, Oracea. |
|
|
|
| 'New drug research is a high-risk game' | 16-APR-09 |
|
| Lupin Ltd, one of the top five drug companies in India, grew over 30 per cent yearly in the past four years and maintained 38 per cent growth in turnover and 49 per cent growth in profits in the first nine months of 2008-09. Kamal K Sharma, managing director, tells PB Jayakumar the company did it through strategic acquisitions, direct to market strategy in the US and careful selection of products. |
|
|
|
|
|
|
| Lupin launches Ceftriaxone in US | 22-JUL-05 |
|
| The Rs 1,200 crore Lupin Ltd has launched Ceftriaxone, the generic version of Rocephine, in the US market. Lupin had received the FDA approval for the generic product for the US market along with |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
 |
Most Popular |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
Hot Searches |
|
|
|
|
|
|
|
|
|
|
|
|
Content Guide
